Arch Biopartners Inc. (OTCPK:ACHF.F) announced a non-brokered private placement of up to 2,500,000 common shares at a price of CAD 0.50 per common share for gross proceeds of up to CAD 1,250,000 on January 26, 2018. The transaction is expected to close in two equal tranches of CAD 625,000 on February 2, 2018 and March 10, 2018 respectively and is subject to certain conditions including, but not limited to, the receipt of applicable regulatory approvals, including approval of the TSX Venture Exchange as well as the satisfaction of other customary closing conditions. All common shares issued will be subject to a hold period of four months and one day from the closing date.